Page last updated: 2024-10-19

kynurenine and Recrudescence

kynurenine has been researched along with Recrudescence in 12 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Research Excerpts

ExcerptRelevanceReference
" The aim of this article is to present results of contemporary research studies over mutual connections between social cognition, cognitive processes and inflammatory factors significant for the aetiology of recurrent depressive disorders, with particular reference to the role of kynurenine pathways."8.93Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway. ( Galecki, P; Talarowska, M, 2016)
"Several lines of evidence suggest that up-regulation of immune response and alterations of kynurenine pathway function are involved in pathogenesis of schizophrenia."7.85Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia. ( Flis, M; Kandefer-Szerszeń, M; Karakuła-Juchnowicz, H; Kocki, T; Rosa, W; Szymona, K; Urbańska, EM; Zdzisińska, B, 2017)
" The aim of this article is to present results of contemporary research studies over mutual connections between social cognition, cognitive processes and inflammatory factors significant for the aetiology of recurrent depressive disorders, with particular reference to the role of kynurenine pathways."4.93Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway. ( Galecki, P; Talarowska, M, 2016)
"Our results suggest that an imbalance between HPA axis function and tryptophan metabolism could be involved in recurrent depression."3.85The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls. ( de Jonge, P; Doornbos, B; Kema, IP; Penninx, BWJH; Sorgdrager, FJH, 2017)
"Several lines of evidence suggest that up-regulation of immune response and alterations of kynurenine pathway function are involved in pathogenesis of schizophrenia."3.85Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia. ( Flis, M; Kandefer-Szerszeń, M; Karakuła-Juchnowicz, H; Kocki, T; Rosa, W; Szymona, K; Urbańska, EM; Zdzisińska, B, 2017)
"We encountered 32 patients in whom breast cancer recurred 5 or more years after surgery."1.39[Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery]. ( Amano, S; Enomoto, K; Fujisaki, S; Hara, Y; Maeda, T; Nagashima, S; Sakurai, K; Suzuki, S; Tomita, R, 2013)
"Inflammation has been linked to depression and suicide risk."1.37Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. ( Fuchs, D; Galfalvy, HC; Grunebaum, MF; Lapidus, M; Mann, JJ; Oquendo, MA; Postolache, TT; Sublette, ME, 2011)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's1 (8.33)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Gaetani, L1
Boscaro, F1
Pieraccini, G1
Calabresi, P1
Romani, L2
Di Filippo, M1
Zelante, T1
Karpińska, G1
Dobrowolski, JC1
Yinda, CK1
Rector, A1
Zeller, M1
Conceição-Neto, N1
Heylen, E1
Maes, P1
Ghogomu, SM1
Van Ranst, M1
Matthijnssens, J1
Arthanari, SK1
Vanitha, J1
Ganesh, M1
Venkateshwaran, K1
de Lama Caro-Patón, G1
García-Salido, A1
Iglesias-Bouzas, MI1
Guillén, M1
Cañedo-Villaroya, E1
Martínez-Romera, I1
Serrano-González, A1
Casado-Flores, J1
Gale, P2
Chen, X2
Li, H1
Lucero-Prisno, DE1
Abdullah, AS1
Huang, J1
Laurence, C1
Liang, X1
Ma, Z1
Mao, Z1
Ren, R1
Wu, S1
Wang, N1
Wang, P2
Wang, T1
Yan, H1
Zou, Y1
Olsen, KM1
Gabler, NK1
Rademacher, CJ1
Schwartz, KJ1
Schweer, WP1
Gourley, GG1
Patience, JF1
Rauch, JC1
Stokes, RS1
Shike, DW1
Luebbe, KM1
Stalker, LA1
Klopfenstein, TJ1
Funston, RN1
Unger, PA1
Lighaam, LC1
Vermeulen, E1
Kruithof, S1
Makuch, M1
Culver, EL1
van Bruggen, R1
Remmerswaal, EBM1
Ten Berge, IJM1
Emmens, RW1
Niessen, HWM1
Barnes, E1
Wolbink, GJ1
van Ham, SM1
Rispens, T1
Liang, JX1
Lin, J1
Liu, J1
Wang, X1
Zhang, T1
Li, J1
Wu, Y2
Venier, M1
Salamova, A1
Gonçales, VR1
Lian, J1
Gautam, S1
Tilley, RD1
Gooding, JJ1
Kandel, YR1
Bradley, CA1
Chilvers, MI1
Mathew, FM1
Tenuta, AU1
Smith, DL1
Wise, KA1
Mueller, DS1
Lu, N1
Lu, M1
Liu, P1
Xu, H1
Qiu, X1
Hu, S1
Bai, S1
Wu, J1
Xue, S1
Dai, X1
Dharmage, SC1
Abramson, MJ1
Erbas, B1
Bennett, CM1
Svanes, C1
Hui, J1
Axelrad, C1
Lowe, AJ1
Lodge, CJ1
Hoshi, M1
Osawa, Y1
Nakamoto, K1
Morita, N1
Yamamoto, Y1
Ando, T1
Tashita, C1
Nabeshima, T1
Saito, K1
Gianesello, L1
Del Prete, D1
Ceol, M1
Priante, G1
Calò, LA1
Anglani, F1
Vekaria, HJ1
Hubbard, WB1
Scholpa, NE1
Spry, ML1
Gooch, JL1
Prince, SJ1
Schnellmann, RG1
Sullivan, PG1
Zhang, Q1
Hu, R1
Gu, Z1
Zhang, M1
Zhang, Z1
Peng, Y1
Feng, L1
Li, X3
Zhao, C1
Sarfaraz, K1
Gao, L1
Wang, H1
Wan, C1
Leng, J1
Yang, P1
Gao, X1
Gao, J1
Emam, HE1
Saad, NM1
Abdallah, AEM1
Ahmed, HB1
Palombo, M1
Ianus, A1
Guerreri, M1
Nunes, D1
Alexander, DC1
Shemesh, N1
Zhang, H1
Xiong, Q1
Liu, YS1
Hu, LX1
Shi, ZQ1
Ying, GG1
Chen, R1
Hong, X1
Yan, S1
Zha, J1
Gu, H1
Zhong, Q1
Zeng, Y1
Zhang, S1
Bu, Y1
Farghali, M1
Mayumi, M1
Syo, K1
Satoshi, A1
Seiichi, Y1
Takashima, S1
Ono, H1
Ap, Y1
Yamashiro, T1
Ahmed, MM1
Kotb, S1
Iwasaki, M1
Ihara, I1
Umetsu, K1
Hu, B1
Wang, Y2
Quan, J1
Huang, K1
Gu, X1
Zhu, J1
Yan, Y1
Wu, P1
Yang, L1
Zhao, J1
Koók, L1
Nemestóthy, N1
Bélafi-Bakó, K1
Bakonyi, P1
Luo, X1
Zhang, F1
Li, Q1
Xia, Q1
Li, Z1
Ye, W1
Li, S1
Ge, C1
Zakkula, A1
Pulipati, S1
Dittakavi, S1
Bestha, RM1
Zainuddin, M1
Trivedi, RK1
Mullangi, R1
Lo, GH1
Lin, CW1
Tai, CM1
Perng, DS1
Chen, IL1
Yeh, JH1
Lin, HC1
Rocha, GS1
Silva, MKL1
Cesarino, I1
Hazzaa, SM1
Abdelaziz, SAM1
Abd Eldaim, MA1
Abdel-Daim, MM1
Elgarawany, GE1
Larsson, P1
Ljuslinder, I1
Öhlund, D1
Myte, R1
Löfgren-Burström, A1
Zingmark, C1
Ling, A1
Edin, S1
Palmqvist, R1
Murthi, P1
Rajaraman, G1
Erwich, JJHM1
Dimitriadis, E1
Yoon, HG1
Oh, D1
Ahn, YC1
Noh, JM1
Pyo, H1
Cho, WK1
Song, YM1
Park, M1
Hwang, NY1
Sun, JM1
Kim, HK1
Zo, JI1
Shim, YM1
Persano, A1
Quaranta, F1
Taurino, A1
Siciliano, PA1
Iannacci, J1
Malekbala, MR1
Soltani, S1
Abdul Rashid, S1
Abdullah, LC1
Rashid, U1
Nehdi, IA1
Choong, TSY1
Teo, SH1
Xu, P1
Yan, F1
Zhao, Y1
Sun, S1
Ying, L1
Quinzi, V1
Caruso, S1
Mummolo, S1
Nota, A1
Angelone, AM1
Mattei, A1
Gatto, R1
Marzo, G1
Xin, W1
Severino, J1
Venkert, A1
Yu, H1
Knorr, D1
Yang, JM1
Carlson, L1
Hicks, R1
De Rosa, I1
Beckmann, NA1
Bitsch, RG1
Schonhoff, M1
Siebenrock, KA1
Schwarze, M1
Jaeger, S1
Sorgdrager, FJH1
Doornbos, B1
Penninx, BWJH1
de Jonge, P1
Kema, IP1
De Luca, A1
Carvalho, A1
Cunha, C1
Iannitti, RG1
Pitzurra, L1
Giovannini, G1
Mencacci, A1
Bartolommei, L1
Moretti, S1
Massi-Benedetti, C1
Fuchs, D2
De Bernardis, F1
Puccetti, P1
Sakurai, K1
Fujisaki, S1
Nagashima, S1
Maeda, T1
Tomita, R1
Suzuki, S1
Hara, Y1
Enomoto, K1
Amano, S1
Talarowska, M1
Galecki, P1
Vengeliene, V1
Cannella, N1
Takahashi, T1
Spanagel, R1
Szymona, K1
Zdzisińska, B1
Karakuła-Juchnowicz, H1
Kocki, T1
Kandefer-Szerszeń, M1
Flis, M1
Rosa, W1
Urbańska, EM1
Sublette, ME1
Galfalvy, HC1
Lapidus, M1
Grunebaum, MF1
Oquendo, MA1
Mann, JJ1
Postolache, TT1
Hartai, Z1
Klivenyi, P1
Janaky, T1
Penke, B1
Dux, L1
Vecsei, L1
McKiernan, J1
Mellor, DH1
Court, S1
Du, F1
Williamson, J1
Bertram, E1
Lothman, E1
Okuno, E1
Schwarcz, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Longitudinal Study of Inflammatory Pathways in Depression[NCT04159207]160 participants (Anticipated)Observational2019-10-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for kynurenine and Recrudescence

ArticleYear
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway.
    Current pharmaceutical design, 2016, Volume: 22, Issue:8

    Topics: Animals; Cognition; Depressive Disorder; Emotions; Humans; Inflammation; Kynurenine; Recurrence; Sig

2016

Trials

2 trials available for kynurenine and Recrudescence

ArticleYear
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
A controlled trial of pyridoxine supplementation in children with febrile convulsions.
    Clinical pediatrics, 1981, Volume: 20, Issue:3

    Topics: 3-Hydroxyanthranilic Acid; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Kynur

1981

Other Studies

9 other studies available for kynurenine and Recrudescence

ArticleYear
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adult; Biomarkers; Female; Gastrointestinal Microbiome; Humans; Italy; Kynurenine; Male; Metabolomic

2020
The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
    Journal of affective disorders, 2017, Volume: 222

    Topics: Adult; Antidepressive Agents; Chromatography, High Pressure Liquid; Depression; Depressive Disorder,

2017
IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis.
    PLoS pathogens, 2013, Volume: 9, Issue:7

    Topics: Animals; Candida albicans; Candidiasis, Vulvovaginal; Female; Genetic Association Studies; Genetic V

2013
[Indoleamine 2, 3-dioxygenase activity for breast cancer patients with recurrence 5 or more years after surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mid

2013
Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse.
    Psychopharmacology, 2016, Volume: 233, Issue:18

    Topics: Animals; Behavior, Animal; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors;

2016
Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
    Neurotoxicity research, 2017, Volume: 32, Issue:1

    Topics: Adult; Antipsychotic Agents; Clozapine; Female; Humans; Interferon-alpha; Interleukin-4; Kynurenic A

2017
Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.
    Brain, behavior, and immunity, 2011, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cytokines; Depressive Disorder, Major; Duloxetine Hy

2011
Kynurenine metabolism in multiple sclerosis.
    Acta neurologica Scandinavica, 2005, Volume: 112, Issue:2

    Topics: Adolescent; Adult; Erythrocytes; Female; Humans; Kynurenic Acid; Kynurenine; Male; Middle Aged; Mult

2005
Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells.
    Neuroscience, 1993, Volume: 55, Issue:4

    Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; Animals; Astrocytes; Cell Death; Cerebral Cortex; Chronic Dis

1993